PADI-2 humain recombinant, exprimé en cellules du baculovirus infectées par le Sf9, >=60% (SDS - PAGE)

Code: srp0327-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. PADI-2 human has been used in in vitro binding assays.


en savoir plus

Votre prix
$694.38 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. PADI-2 human has been used in in vitro binding assays.

Biochem/physiol Actions

Peptidyl arginine deiminase, protein-2 (PADI2) promotes protein citrullination and represses the multiplication of cells. It helps to transform the amino acid arginine in a protein into amino acid citrulline. PADI2 participates in epigenetic mechanisms. It is linked with rheumatoid arthritis.

General description

Human PADI2, also known as Peptidyl arginine deiminase, type II, (GenBank Accession No. NM_007365), amino acids 1-665 (end) with C-terminal FLAG-tag, MW= 77kDa, expressed in a Baculovirus infected Sf9 cell expression system. Peptidyl arginine deiminase, protein-2 (PADI2) is mapped to human chromosome 1p36. It is expressed in Sertoli cells at the time of testicular development.

Physical form

Formulated in 40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 80 ng/uL Flag peptide, 3 mMDTT, and 20% Glycerol.

assay≥60% (SDS-PAGE)
biological sourcehuman
formaqueous solution
Gene Informationhuman ... PADI2(11240)
mol wt77 kDa
NCBI accession no.NM_007365
packagingpkg of 10 µg
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
storage temp.−70°C
UniProt accession no.Q9Y2J8
Ce produit répond aux critères suivants: